BME100 s2015:Group16 12pmL2

BME 100 Spring 2015	Home People Lab Write-Up 1 | Lab Write-Up 2 | Lab Write-Up 3 Lab Write-Up 4 | Lab Write-Up 5 | Lab Write-Up 6 Course Logistics For Instructors Photos Wiki Editing Help
OUR TEAM Name: Trevaun Walker Name: Thomas Murphy Name: Hanna Monroe Name: Natkanes Pakjirasirikul Name: Reaghan Fletcher LAB 2 WRITE-UP Descriptive Statistics Experiment 1 This was a human based study to see if various doses of LPS (0 mg, 5 mg, 10 mg, and 15 mg) increase the levels of inflammotin in the elderly at a retirement center. Experiment 2 This was a rat based study to see if the LPS treatment increased Inflammotin protein levels Results Experiment 1 ‎Experiment 2 Analysis Experiment 1 Experiment 2 Summary/Discussion Based on the p-value for experiment 1, there is a statistically significant difference among the different doses of LPS. Upon further analysis between all groups, each comparison showed significance when comparing the t-test values to the corrected p-value. In this study of inflammotin and the elderly, we found that the dose of LPS does make a difference in the amount of inflammotin in elderly. However, in experiment 2, there was no significant difference between the doses of LPS. The dose of LPS does not make a significant difference in the amount of inflammotin.